Position in BIIB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$40,036,134
+$34,579,867 QoQ
Shares Held
185,301
+522.6% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#74
of 1,031 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NISSAY ASSET MANAGEMENT CORP /JAPAN holds $652,967,715 across 10 Drug Manufacturers - General names. BIIB ranks #7 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
165,404 | $198,390,536 | |
| 2 | ABBV |
AbbVie Inc.
|
568,521 | $143,062,624 | |
| 3 | JNJ |
Johnson & Johnson
|
335,504 | $85,207,950 | |
| 4 | AMGN |
Amgen Inc
|
159,700 | $57,830,564 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
371,019 | $46,874,540 | |
| 6 | MRK |
Merck & Co., Inc.
|
336,267 | $43,210,309 | |
| 7 | BIIB |
Biogen Inc.
This page
|
185,301 | $40,036,134 | |
| 8 | PFE |
Pfizer Inc
|
795,895 | $19,165,151 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,036,134 | 185,301 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,456,267 | 29,762 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,626,073 | 26,286 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,369,717 | 45,472 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,628,692 | 44,818 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,459,395 | 47,204 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,709,976 | 43,879 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,238,200 | 42,500 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,251,472 | 39,908 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,974,552 | 32,345 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,031,523 | 19,444 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,544,193 | 17,681 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,660,715 | 16,362 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,563,306 | 16,413 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,715,947 | 17,030 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,600,944 | 17,232 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,398,864 | 16,666 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,498,487 | 16,612 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,946,684 | 16,450 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,930,817 | 17,424 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $5,906,327 | 17,057 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,194,118 | 18,567 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $4,729,715 | 19,316 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $5,748,207 | 20,263 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $6,563,269 | 24,531 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $7,791,806 | 24,628 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||